Xamamina

Xamamina is owned by Dompé farmaceutici S.p.A., headquartered in Italy. No. The ultimate owner of Xamamina, Dompé farmaceutici S.p.A., is headquartered in Italy, not in the United States.

A leading Italian biopharmaceutical company focused on primary care and innovative treatments for rare diseases.